Skip Navigation


Annals of Oncology Advance Access originally published online on December 10, 2007
Annals of Oncology 2008 19(1):5-7; doi:10.1093/annonc/mdm555
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/1/5    most recent
mdm555v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Maltoni, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maltoni, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology. For Permissions, please email: journals.permissions@oxfordjournals.org

editorials

Opioids, pain, and fear

M. Maltoni

Palliative Care Unit, Division of Oncology, Forlì Local Health Authority, Forlì and Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy

(E-mail: malto.ma@tin.it)

The first 150 words of the full text of this article appear below.

Cancer pain has been described as ‘total pain’ presenting physical, psychological, social, and spiritual components [1], and can thus be defined as a ‘biopsychosocial experience’ [2]. It is very difficult to identify the specific ‘percentage’ of each of these components for a given value in a numerical scale of pain assessment although it has been reported that emotional and cognitive components seem to be proportionally more important in cancer pain than in noncancer pain [3]. As cancer pain is a multifactorial experience and is present together with numerous other symptoms, pain management within the context of palliative care plays an important role in the systematic control of symptoms [4]. In fact, global and continuous palliative interventions in patients bring about a substantial reduction in the dose of opioids used for cancer pain management [5]. Cancer pain must therefore be dealt . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
S. Deandrea, M. Montanari, L. Moja, and G. Apolone
Prevalence of undertreatment in cancer pain. A review of published literature
Ann. Onc., December 1, 2008; 19(12): 1985 - 1991.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Apolone, O. Corli, M. T. Greco, V. Zagonel, and on behalf of the CPOR SG Investigators
Factors influencing the decision to take or reject opioids for cancer pain: are we on target?
Ann. Onc., May 1, 2008; 19(5): 1021 - 1022.
[Full Text] [PDF]